Independent association of type 2 diabetes and coronary artery disease with myocardial insulin resistance

Diabetes

Volumn 51, Issue 10, 2002, Pages 3020-3024

  Iozzo, Patricia ^a,b   Chareonthaitawee, Panithaya ^a   Dutka, David ^a   John Betteridge, D ^c   Ferrannini, Ele ^b   Camici, Paolo G ^a,d  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE; INSULIN; OXYGEN 15;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DISEASE ASSOCIATION; GLUCOSE TRANSPORT; HEART MUSCLE; HEART MUSCLE PERFUSION; HUMAN; HYPERINSULINEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

EID: 0036788287     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.51.10.3020     Document Type: Article

References (36)

1. Grundy SM, Benjamin IJ, Burke GL, Chait A, Eckel RH; Howard BV, Mitch W, Smith SC, Sowers JR: Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Society. Circulation 100:1134-1146, 1999
2. Camici P, Ferrannini E, Opie LH: Myocardial metabolism in ischemic heart disease: basic principles and application to imaging by positron emission tomography. Prog Cardiovasc Dis 32:217-238, 1989
3. Fath-Ordoubadi F, Pagano D, Marinho NVS, Keogh BE, Bonser RS, Camici PG: Coronary revascularization in the treatment of moderate and severe postischemic left ventricular dysfunction. Am J Cardiol 82:26-31, 1998
4. Maki M, Luotolahti M, Nuutila P, Iida H, Voipio-Pulkki LM, Ruotsalainen U, Haaparanta M, Solin O, Hartiala J, Harkonen R, Knuuti J: Glucose uptake in the chronically dysfunctional but viable myocardium. Circulation 93:1658-1666, 1996
5. Paternostro G, Camici PG, Lammerstma AA, Marinho N, Baliga RR, Kooner JS, Radda GK, Ferrannini E: Cardiac and skeletal muscle insulin resistance in patients with coronary heart disease. J Clin Invest 98:2094-2099, 1996
6. Marinho NVS, Keogh BE, Costa DC, Lammerstma AA, Ell PJ, Camici PG: Pathophysiology of chronic left ventricular dysfunction: new insights from the measurement of absolute myocardial blood flow and glucose utilization. Circulation 93:737-744, 1996
7. Nuutila P, Knuuti J, Ruotsalainen U, Koivisto VA, Eronen E, Teras M, Bergman J, Haaparanta M, Voipio-Pulkki LM, Viikari J, et al: Insulin resistance is localized to skeletal but not heart muscle in type 1 diabetes. Am J Physiol 264:E756-E762, 1993
8. Vom Dahl J, Heman WH, Hicks RJ, Ortiz-Alonso FJ, Allman KC Wolfe ER, Kalff V, Schwaiger M: Myocardial glucose uptake in patients with insulin-dependent diabetes mellitus assessed quantitatively by dynamic positron emission tomography. Circulation 88:395-404, 1993
9. Ohtake T, Yokoyama I, Watanabe T, Momose T, Serezawa T, Nishikawa J, Yasuhito S: Myocardial glucose metabolism in noninsulin-dependent diabetes mellitus patients evaluated by FDG-PET. J Nucl Med 36: 456-463, 1995
10. Yokoyama I, Yonekura K, Ohtake T, Kawamura H, Matsumoto A, Inoue Y, Aoyagi T, Sugiura S, Omata M, Ohtomo K, Nagai R: Role of insulin resistance in heart and skeletal muscle F-18 fluorodeoxyglucose uptake in patients with non-insulin-dependent diabetes mellitus. J Nucl Cardiol 7:242-248, 2000
11. Voipio-Pulkki LM, Nuutila P, Knuuti MJ, Ruotsalainen U, Haaparanta M, eras M, Wegelius U, Koivisto VA: Heart and skeletal muscle glucose disposal in type 2 diabetic patients as determined by positron emission tomography. J Nucl Med 34:2064-2067, 1993
12. Maki M, Nuutila P, Laine H, Voipio-Pulkki LM, Haaparanta M, Solin O, Knuuti JM: Myocardial glucose uptake in patients with NIDDM and stable coronary artery disease. Diabetes 46:1491-1496, 1997
13. Utriainen T, Takala T, Luotolahti M, Ronnemaa T, Laine H, Ruostalainen U, Haaparanta M, Nuutila P, Yki-Jarvinen H: Insulin resistance characterizes glucose uptake in skeletal muscle but not in the heart in NIDDM. Diabetologia 41:555-559, 1998
14. Hoffmann EJ, Phelps ME, Huang SC, Shelbert HR: Dynamic, gated and high resolution imaging with the ECAT III. IEEE Trans Nucl Sci 33:452-455, 1986
15. Spinks TJ, Jones T, Gilardi MC, Heather JD: Physical performance of the latest generation of commercial positron scanner. IEEE Trans Nucl Sci 35:721-725, 1988
16. Hermansen F, Rosen SD, Fath-Ourdubadi F, Kooner JS, Clark JC, Camici PG, Lammertsma AA: Measurement of myocardial blood flow with oxygen-15 labelled water: comparison of different administration protocols. Eur J Nucl Med 25:751-759, 1998
17. Hermansen F, Ashburner, J, Spinks TJ, Kooner JS, Camici PG, Lammerstma AA: Generation of myocardial factor images directly from the dynamic oxygen-15-water scan without use of an oxygen-15-carbon monoxide blood-pool scan. J Nucl Med 39:1696-1702, 1998
18. DeFronzo RA, Tobin JD, Andres R: Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223, 1979
19. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I, et al: Recommendations for quantitation of the left ventricle by two-dimensional echocardiography: American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms.
20. Loenzoni R, Pagano D, Boyd H, Camici PG: A report system for PET assessment of myocardial viability. Nucl Med Commun 20:895-899, 1999
21. Bøtker HE, Bottcher M, Schmitz O, Gee A, Hansen SB, Cold GE, Nielsen TT, Gjedde A: Glucose uptake and lumped constant variability in normal human hearts determined with [18F]-fluorodeoxyglucose. J Nucl Cardiol 4:125-132, 1997
22. Chin KN, Soufer R, McNulty PH: Effect of hyperinsulinemia on myocardial fluorine-18-FDG uptake. J Nucl Med 39:379-383, 1998
23. Peltoniemi P, Lönnroth P, Laine H, Oikonen V, Tolvanen T, Grönrros T, Strindberg L, Knuuti J, Nuutila P: Lumped constant for [(18)F]fluorode-oxyglucose in skeletal muscles of obese and nonobese humans. Am J Physiol Endocrinol Metab 27:E1122-E1130, 2000
24. Utriainen T, Lovisatti S, Makimattila S, Bertoldo A, Weintraub S, DeFronzo R, Cobelli C, Yki-Jarvinen H: Direct measurement of the lumped constant for 2-deoxy-[1-(14)C]glucose in vivo in human skeletal muscle. Am J Physiol 279:E228-E233, 2000
25. Kelley DE, Williams KV, Price JC, Goodpaster B: Determination of the lumped constant for [18F] fluorodeoxyglucose in human skeletal muscle. J Nucl Med 40:1798-1804, 1999
26. Depre C, Vanoverschelde J-LJ, Melin JA, Borges M, Bol A, Ausma J, Dion R, Wijns W: Structural and metabolic correlates of the reversibility of chronic left ventricular ischemic dysfunction in humans. Am J Physiol 268:H1265-H1275, 1995
27. Diabetes mellitus: a major risk factor for cardiovascular disease. A joint editorial statement by the American Diabetes Association; the National Heart, Lung, and Blood Institute; the Juvenile Diabetes Foundation International; the National Institute of Diabetes and Digestive and. Kidney Diseases; and the American Heart Association. Circulation 100: 1132-1133, 1999
28. Meyer C, Schwaiger M: Myocardial blood flow and glucose metabolism in diabetes mellitus. Am J Cardiol 80:94A-101A, 1997
29. Ferrannini E: Insulin resistance versus insulin deficiency in non-insulin-dependent diabetes mellitus: problems and prospects. Endocr Rev 19:477-490, 1998
30. Yki-Jarvinnen H, Koivisto VA: Natural course of insulin resistance in type 1 diabetes. N Engl J Med 315:224-230, 1986
31. Yki-Jarvinen H: Acute and chronic effects of hyperglycaemia on glucose metabolism: implications for the development of new therapies. Diabet Med 14:S32-S37, 1997
32. Laarsko M: Hyperglycemia and cardiovascular disease in type 2 diabetes. Diabetes 48:937-942, 1999
33. Barrett EJ, Schwarz RG, Francis CK, Zaret BL. Regulation by insulin of myocardial glucose and fatty acid metabolism in the conscious dog. J Clin Invest 74:1073-1079, 1984
34. Nuutila P, Koivisto VA, Knuuti J, Ruotsalainen U, Teras M, Haaparanta M, Bergman J, Solin O, Voipio-Pulkki LM, Wegelius U, Yki-Järvinen H: Glucose-free fatty acid cycle operates in human heart and skeletal muscle in vivo. J Clin Invest 89:1767-1774, 1992
35. Swan JW, Anker SD, Walton C, Godsland IA, Clark AL, Leyva F, Stevenson JC, Coats AJKS: Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure. J Am Coll Cardiol 30:527-532, 1997
36. Paternostro G, Pagano D, Gnecchi-Ruscone T, Bonser RS, Camici PG: Insulin resistance in patients with cardiac hypertrophy. Cardiovasc Res 42:246-253, 1999